In this study bilirubin was measured in 216 coronary patients over 5 years in which 434 examinations were conducted. Bilirubin levels were significantly lower among the coronary patients than within the control group.
En este estudio, la bilirrubina fue medida en 216 sujetos quienes habían desarrollado enfermedad coronaria a los 5 años de seguimiento y en 434 controles.